BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28495197)

  • 1. Randomized, allopurinol-controlled trial of the effects of dietary nucleotides and active hexose correlated compound in the treatment of canine leishmaniosis.
    Segarra S; Miró G; Montoya A; Pardo-Marín L; Boqué N; Ferrer L; Cerón J
    Vet Parasitol; 2017 May; 239():50-56. PubMed ID: 28495197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of disease progression in Leishmania infantum-infected dogs with dietary nucleotides and active hexose correlated compound.
    Segarra S; Miró G; Montoya A; Pardo-Marín L; Teichenné J; Ferrer L; Cerón JJ
    Parasit Vectors; 2018 Feb; 11(1):103. PubMed ID: 29467015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of Artesunate in the treatment of visceral leishmaniasis in dogs naturally infected by Leishmania infantum: Efficacy evidence from a randomized field trial.
    Medkour H; Bitam I; Laidoudi Y; Lafri I; Lounas A; Hamidat HK; Mekroud A; Varloud M; Davoust B; Mediannikov O
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008947. PubMed ID: 33338041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, blinded, controlled clinical trial comparing the efficacy of aminosidine (paromomycin)-allopurinol combination with the efficacy of meglumine antimoniate-allopurinol combination for the treatment of canine leishmaniosis due to Leishmania infantum.
    Kasabalis D; Chatzis MK; Apostolidis K; Petanides T; Athanasiou LV; Xenoulis PG; Mataragka A; Ikonomopoulos J; Leontides LS; Saridomichelakis MN
    Exp Parasitol; 2020 Jul; 214():107903. PubMed ID: 32360142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of nephrotoxicity and ototoxicity of aminosidine (paromomycin)-allopurinol combination in dogs with leishmaniosis due to Leishmania infantum: A randomized, blinded, controlled study.
    Kasabalis D; Chatzis MK; Apostolidis K; Xenoulis PG; Buono A; Petanides T; Leontides LS; Polizopoulou ZS; Steiner JM; Suchodolski JS; Saridomichelakis MN
    Exp Parasitol; 2019 Nov; 206():107768. PubMed ID: 31539540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
    Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
    Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate.
    Pasa S; Toz SO; Voyvoda H; Ozbel Y
    Vet Parasitol; 2005 Mar; 128(3-4):243-9. PubMed ID: 15740861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy.
    de Jong MK; Rappoldt A; Broere F; Piek CJ
    Parasit Vectors; 2023 May; 16(1):163. PubMed ID: 37189181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of the sesquiterpene (-)-α-bisabolol in dogs with naturally acquired canine leishmaniosis: an exploratory clinical trial.
    Corpas-López V; Merino-Espinosa G; Acedo-Sánchez C; Díaz-Sáez V; Navarro-Moll MC; Morillas-Márquez F; Martín-Sánchez J
    Vet Res Commun; 2018 Jun; 42(2):121-130. PubMed ID: 29453596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania infantum-specific IFN-γ production in stimulated blood from dogs with clinical leishmaniosis at diagnosis and during treatment.
    Martínez-Orellana P; Marí-Martorell D; Montserrat-Sangrà S; Ordeix L; Baneth G; Solano-Gallego L
    Vet Parasitol; 2017 Dec; 248():39-47. PubMed ID: 29173539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis.
    Miró G; Oliva G; Cruz I; Cañavate C; Mortarino M; Vischer C; Bianciardi P
    Vet Dermatol; 2009 Oct; 20(5-6):397-404. PubMed ID: 20178476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of serum pancreatic lipase immunoreactivity and troponin I concentrations in Leishmania infantum-infected dogs treated with meglumine antimonate.
    Xenoulis PG; Saridomichelakis MN; Chatzis MK; Kasabalis D; Petanides T; Suchodolski JS; Steiner JM
    Vet Parasitol; 2014 Jul; 203(3-4):326-30. PubMed ID: 24813787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.
    Manna L; Vitale F; Reale S; Picillo E; Neglia G; Vescio F; Gravino AE
    Vet J; 2009 Dec; 182(3):441-5. PubMed ID: 18818112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR-2 and TLR-4 transcriptions in unstimulated blood from dogs with leishmaniosis due to Leishmania infantum at the time of diagnosis and during follow-up treatment.
    Montserrat-Sangrà S; Alborch L; Ordeix L; Solano-Gallego L
    Vet Parasitol; 2016 Sep; 228():172-179. PubMed ID: 27692322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of two treatments on changes in serum acute phase protein concentrations in dogs with clinical leishmaniosis.
    Daza González MA; Fragío Arnold C; Fermín Rodríguez M; Checa R; Montoya A; Portero Fuentes M; Rupérez Noguer C; Martínez Subiela S; Cerón JJ; Miró G
    Vet J; 2019 Mar; 245():22-28. PubMed ID: 30819422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the concentration of anti-Leishmania antibodies in saliva of dogs with clinical leishmaniosis after short-term treatment.
    Cantos-Barreda A; Escribano D; Cerón JJ; Tecles F; Bernal LJ; Martínez-Subiela S
    Vet Parasitol; 2018 Apr; 254():135-141. PubMed ID: 29656998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous immune mechanisms in canine leishmaniosis due to Leishmania infantum.
    Papadogiannakis EI; Koutinas AF
    Vet Immunol Immunopathol; 2015 Feb; 163(3-4):94-102. PubMed ID: 25555497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and clinical management of canine leishmaniosis by general veterinary practitioners: a questionnaire-based survey in Portugal.
    Monteiro M; Prata S; Cardoso L; Pereira da Fonseca I; Leal RO
    Parasit Vectors; 2021 Jun; 14(1):306. PubMed ID: 34099039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of acute-phase proteins in dogs with leishmaniosis during short-term treatment.
    Martínez-Subiela S; Bernal LJ; Cerón JJ
    Am J Vet Res; 2003 Aug; 64(8):1021-6. PubMed ID: 12926596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different tissue sampling for PCR-based diagnosis and follow-up of canine visceral leishmaniosis.
    Manna L; Vitale F; Reale S; Caracappa S; Pavone LM; Morte RD; Cringoli G; Staiano N; Gravino AE
    Vet Parasitol; 2004 Nov; 125(3-4):251-62. PubMed ID: 15482882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.